US measles surge threatens elimination status, decision pending

US measles surge threatens elimination status, decision pending

Public health experts in the United States warn that a surge in measles cases could jeopardize the country's measles elimination status. They say the increase, driven by declining vaccination rates, has raised concerns that the United States may lose its designation. The Pan American Health Organization and leading epidemiologists note that a formal determination on the status is slated for later this year. According to the San Francisco Chronicle, experts emphasize that the decision could be made as early as November. The potential loss would represent the first reversal of the country's measles-free status since the early 1990s.

Subsequent reporting in the New York Post cites epidemiologists who say the number of measles infections is on track to exceed the previous record. They attribute the upward trend to gaps in vaccination coverage across several states. The experts caution that without increased immunization efforts, the case count could reach a 35-year high. They note that the projected surge reinforces the urgency of the pending status review.

Acteurs

United States Pan American Health Organization Dr. Jake Scott Stanford University Dr. George Rutherford University of California, San Francisco

Lieux

Aucun enregistrement

Articles

1 juillet 2026
1 au total
'World's most contagious disease' on track for highest US cases in 35 years
'World's most contagious disease' on track for highest US cases in 35 years

New York Post • 01 juil. 17h25

Epidemiologists warn that measles infections in the United States are on track to surpass the 2025 record, with vaccination gaps fueling the surge.

Crédibilité 68% Manip. 32% Centre
27 juin 2026
1 au total
US may have lost a ‘crown jewel’ of public health
US may have lost a ‘crown jewel’ of public health

San Francisco Chronicle • 27 juin 11h00

Experts warn that the United States could lose its measles elimination designation as domestic cases surge and vaccination rates decline, with a formal decision expected in November.

Crédibilité 72% Manip. 32% Centre